financetom
DRS
financetom
/
Industrials
/
DRS
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Leonardo DRS, Inc.DRS
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Leonardo DRS, Inc., together with its subsidiaries, provides defense electronic products, systems, and military support service.

It operates through Advanced Sensing and Computing (ASC) segment, and Integrated Mission Systems (IMS) segments.

The ASC segment designs, develops, and manufacture sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision making and execution; and offers sensing capabilities span applications, such as missions requiring advanced detection, precision targeting and surveillance sensing, long range electro-optic/infrared, signals intelligence, and other intelligence systems including electronic warfare, ground vehicle sensing, active electronically scanned array tactical radars, dismounted soldier, and space sensing.

This segment also provides network computing, which is utilized across a range of mission applications including platform computing on ground and shipboard for advanced battle management, combat systems, radar, command and control, tactical networks, tactical computing, and communications.

Its IMS segment designs, develops, manufacture, and integrates power conversion, control, and distribution systems, ship propulsion systems, motors and variable frequency drives, force protection systems, transportation, and logistics systems for the U.S. and allied defense customers.

This segment also offers naval power and propulsion systems, which includes power conversion, control, distribution, and propulsion systems, as well as power dense permanent magnet motors, energy storage systems and associated efficient, rugged and compact power conversion, electrical actuation systems, and cooling technologies; and motor controllers, instrumentation and control equipment, electrical actuation systems, and thermal management systems.

The company was incorporated in 1968 and is based in Arlington, Virginia. Leonardo DRS, Inc. operates as a subsidiary of Leonardo S.p.a.

Latest News >
UBS on Canadian Grocers Q1 Preview
UBS on Canadian Grocers Q1 Preview
Apr 11, 2025
01:00 PM EDT, 04/11/2025 (MT Newswires) -- Canadian grocers were navigating a challenging backdrop in the first quarter, notes UBS. The tariff situation is adding to an already soft consumer confidence environment. The loonie was also down ~6% relative to the greenback, impacting consumer purchasing power. Still, there were some glimmers of improvement. Statistics Canada's Food & Beverage Store Retail...
US oil rig count falls by most in a week since June 2023, Baker Hughes says
US oil rig count falls by most in a week since June 2023, Baker Hughes says
Apr 11, 2025
April 11 (Reuters) - U.S. energy firms this week cut oil rigs by the most in a week since June 2023, lowering the total oil and natural gas rig count for a third consecutive week, energy services firm Baker Hughes ( BKR ) said in its closely followed report on Friday. The oil and gas rig count, an early indicator...
Exchange-Traded Funds, US Equities Advance After Midday Friday
Exchange-Traded Funds, US Equities Advance After Midday Friday
Apr 11, 2025
01:11 PM EDT, 04/11/2025 (MT Newswires) -- Broad Market Indicators Broad-market exchange-traded funds IWM and IVV rose. Actively traded Invesco QQQ Trust (QQQ) added 1.3%. US equity indexes rose in choppy midday trading Friday amid continuing sharp declines in government bond prices and the dollar as producer prices eased and the trade war with China intensified. Energy IShares US Energy...
BioCardia Says Emory University Enrolling Heart Patients for CardiAMP HF II Trial
BioCardia Says Emory University Enrolling Heart Patients for CardiAMP HF II Trial
Apr 11, 2025
01:03 PM EDT, 04/11/2025 (MT Newswires) -- BioCardia ( BCDA ) said Friday that Emory University School of Medicine in Atlanta has started enrolling patients with ischemic heart failure in the company's ongoing phase 3 CardiAMP HF II trial. The CardiAMP HF II therapy is a system designed for the harvest, processing and minimally invasive delivery of autologous mononuclear cells...
Copyright 2023-2026 - www.financetom.com All Rights Reserved